
Sign up to save your podcasts
Or


NRG Oncology Podcast co-hosts talk with Dr. Vinai Gondi, the Principal Investigator of the NRG-CC009 phase III clinical study assessing stereotactic radiosurgery (SRS) versus hippocampal-avoidant whole brain radiotherapy (HA-WBRT) for patients who have brain metastases (or cancer that has spread to the brain) from their small cell lung cancer (SCLC).
By NRG Oncology5
1010 ratings
NRG Oncology Podcast co-hosts talk with Dr. Vinai Gondi, the Principal Investigator of the NRG-CC009 phase III clinical study assessing stereotactic radiosurgery (SRS) versus hippocampal-avoidant whole brain radiotherapy (HA-WBRT) for patients who have brain metastases (or cancer that has spread to the brain) from their small cell lung cancer (SCLC).

30,649 Listeners

43,765 Listeners

112,617 Listeners

56,472 Listeners

9,505 Listeners

6,445 Listeners

61 Listeners

3,000 Listeners

5,518 Listeners

9,909 Listeners

16,081 Listeners

10,892 Listeners

2,287 Listeners

189 Listeners

37 Listeners